Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05594953 · ClinicalTrials.gov registry record

Outcomes Using MARS for Patients With ALF

A clinical trial, sponsored by Methodist Health System.

Completed
Registry status
27
Enrollment target

NCT05594953 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 27 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05594953 has completed, sponsored by Methodist Health System.

COMPLETED
Registry status
27 participants
Enrollment target

Study Summary

Retrospective chart review will be conducted on patients at Methodist Dallas Medical Center, meeting the inclusion criteria from January 1, 2019 to December 15, 2020 to determine the transplant free survival and overall survival and other secondary outcome measures.

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2021-04-23
Est. Completion 2026-05-12

Sponsor

Methodist Health System

125 total trials

What the Registry Record Tells You About NCT05594953

The ClinicalTrials.gov registry entry for NCT05594953 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT05594953 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05594953 about?

NCT05594953 is a clinical study titled "Outcomes Using MARS for Patients With ALF". Retrospective chart review will be conducted on patients at Methodist Dallas Medical Center, meeting the inclusion criteria from January 1, 2019 to December 15, 2020 to determine the transplant free survival and overall survival and other secondary outcome measures.

What is the current status of trial NCT05594953?

This trial is currently completed. The enrollment target is 27 participants. The study started on 2021-04-23. Estimated completion is 2026-05-12.

Who is sponsoring clinical trial NCT05594953?

This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.